Skip to the content
Know your tech before you buy it. Makers: get listed from $49/mo

Chemistry42

By Insilico Medicine · pharma.ai

  • Web
6.1 Club score Visit pharma.ai

What the maker publishes

ADMET and selectivity
Predictive models profile and optimize ADMET and selectivity, including as standalone tools or within generative experiments. source
Audience and access
The page has a dedicated offering for academia and startups, and links to sign up and log in through Chemistry42 Cloud. source
Binding free energy
Alchemistry computes relative protein-ligand binding free energy to help prioritize lead compounds. source
Building blocks
The retrosynthesis tool includes a collection of 300,000 commercially available building blocks. source
Concurrency limit
Tokens govern how many experiments users in an organization can run simultaneously; token requirements vary by experiment settings. source
Data hosting
The privacy policy states SaaS data is processed in Seoul for cloud.chemistry42.com subscriptions and in Ireland for lab.chemistry42.com subscriptions. source
External tools
The platform can be customized with external QSAR models, MD simulators, and in-house databases. source
Generative chemistry
The platform supports de novo design, hit optimization, scaffold hopping, and R-group search. source
Model training
Users can train predictive models on their own data, including in vitro activity or simulation data. source
Molecular dynamics
MDFlow provides simulation workflows for biomolecules and complexes, from system building and sampling through reporting. source
Purpose
Chemistry42 is a small-molecule drug discovery platform for hit identification, hit-to-lead, and lead optimization. source
Retrosynthesis
It predicts synthetic routes for uploaded or generated molecular structures using expert-annotated reaction templates. source
Security caveat
The privacy policy says the company uses commercially acceptable protective measures but cannot guarantee absolute security. source
Subscription use
The terms limit subscription use to internal drug discovery by the customer organization and its affiliates. source
Support
The terms say Insilico will use reasonable commercial efforts to host, support, and maintain the subscription. source

Checked against the maker's pages on 14 Nov 2026.